13-month-old receives liver transplant in Dubai
ABU DHABI (ALETIHAD)In a medical breakthrough for the emirate of Dubai and in a testament to the synergy between the public and private healthcare sectors, a medical team at King's College Hospital London in Dubai has successfully performed the city's first liver transplant on a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health.The successful transplant marks another milestone in Dubai's relentless quest for healthcare excellence, aligning with the objectives of the Dubai Social Agenda 33, which aims to develop a more efficient, high-quality healthcare system in line with the highest global standards.The complex and delicate surgery was led by Professor Mohamed Rela, one of the world's foremost liver transplant surgeons, and was carried out by a multidisciplinary team at King's College Hospital London in Dubai. Al Jalila Children's Hospital played a vital role in preparing for the transplant by providing specialised medical care to both the infant and his father, who donated a portion of his liver.Al Jalila Children's also performed cardiac surgery to repair a hole in the child's heart – a key step that paved the way for the successful liver transplant.The child, named Malek, was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect).He was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure, as part of its ongoing commitment to supporting critical humanitarian cases and providing advanced treatment options for children within the UAE.The collaborative medical intervention by Al Jalila Children's and King's College Hospital London in Dubai, and the successful transplant, gave the child a renewed chance at life. The surgery was completed successfully, and the patient was discharged in good health.Dr. Younis Kazim, Acting CEO of the Health Regulation Sector at the Dubai Health Authority (DHA), said, 'The successful liver transplant for a 13-month-old infant represents an unprecedented medical achievement for Dubai. It reflects the healthcare system's readiness and ability to handle the most complex cases with efficiency and professionalism in a dynamic environment that fosters excellence and supports high-value healthcare investments.'Spirit of partnershipDr. Kazim highlighted the Authority's commitment to empowering and developing private healthcare facilities as key partners in delivering specialised services. He noted that the DHA enables this through advanced regulatory frameworks, flexible policies, and continued support to attract top global talent, further reinforcing Dubai's position as a leading regional and global healthcare hub.He added that DHA's efforts to establish comprehensive, internationally-aligned standards for organ transplant procedures in the UAE are rooted in global best practices. These efforts reflect Dubai's model of excellence in service quality, transparency, and governance of medical procedures, ensuring patient safety, enhancing transplant outcomes, and strengthening trust in the city's healthcare system.
Dr. Kazim concluded by stating that the medical milestone and the integrated care provided to the young patient underscore Dubai's steady and confident progress towards its strategic goal of becoming the world's best city in terms of quality of life, wellbeing, and healthcare.
Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, affirmed that the achievement marks a significant leap forward for Dubai's healthcare sector and reflects Dubai Health's unwavering commitment to elevating the standard of care in line with the highest global standards.Dr. Al Zarooni expressed his appreciation to all partners involved in the success of the exceptional procedure, describing it as a model of collaboration between the public and private sectors and charitable organisations. He also praised the vital role of donors and their invaluable contributions to supporting organ transplant programmes backed by Al Jalila Foundation, highlighting their profound impact on the lives of patients with critical medical conditions.He noted that Al Jalila Foundation covered the full medical costs for the infant Malek, including comprehensive pre- and post-operative care provided at Al Jalila Children's Hospital. This support reflects the Foundation's ongoing pledge to provide comprehensive healthcare services to those in need, in line with Dubai Health's guiding principle: Patient First.Strategic collaborationIt is worth noting that Al Jalila Foundation signed a cooperation agreement with King's College Hospital London in Dubai during Arab Health 2025. The agreement aims to expand charitable healthcare initiatives in the UAE by supporting organ transplant programmes.Meanwhile, Dr. Hanan Ali Obaid, Director of Health Policies and Standards at the Dubai Health Authority, stated that the success of Dubai's first paediatric liver transplant underscores DHA's commitment to providing a comprehensive regulatory environment that meets the highest international standards of patient care and safety.Dr. Obaid emphasised the Authority's focus on adopting advanced and flexible regulatory frameworks that empower healthcare institutions to achieve such complex and precise medical milestones locally. She explained that Dubai's organ transplant standards have been developed in alignment with global best practices, conforming to all medical, ethical, and humanitarian considerations to ensure the efficacy and safety of the procedure aligned with the Authority's vision, values, and principles, which place the individual at the heart of healthcare services. This achievement is part of an integrated system that bolsters patient confidence and reinforces Dubai's status as a global hub for specialised healthcare.Professor Mohamed Rela – who previously performed a liver transplant on a five-day-old infant, a case recorded in the Guinness World Records as the youngest liver transplant globally – explained that Malek's condition was particularly complex due to his young age, low weight, and multiple health complications. He emphasised that the successful outcome highlights the competence of the multidisciplinary medical team and the robustness of the specialised programme, which brings together elite consultants, surgeons, hepatologists, anaesthetists, and intensive care experts to deliver holistic, integrated care designed to save lives.Rapid advancementsHe added that the breakthrough also reflects the rapid advancements in the capabilities of Dubai's healthcare sector and embodies the hospital's commitment to realising the emirate's vision of delivering the highest standards of comprehensive healthcare to all members of society, including children.Dr. Rajeev Tomar, Consultant Paediatrician and Director of the Paediatric Liver Transplant Programme at King's College Hospital London in Dubai, stated that initial examinations for the infant, Malek, showed severe jaundice, liver and spleen enlargement, and severe malnutrition, indicating that a liver transplant was the only option to save his life. He explained that the case was one of the most challenging handled by the medical team, especially given the presence of a heart defect, which was successfully treated at Al Jalila Hospital before performing the liver transplant.Kimberly Pierce, CEO of King's College Hospital Dubai, said: 'The success of the surgery represents a qualitative shift in the healthcare landscape of the emirate, as the hospital was able to meet an urgent medical need that previously required travel abroad. Now, it is available locally, thanks to the supportive guidance and the integrated healthcare system that Dubai embraces.'Dr. Tashfeen Siddiq Ali, Chief Medical Officer at King's College Hospital London in Dubai, stated that this achievement marks a turning point in Dubai's journey to becoming a global hub for specialised healthcare.
He added, 'It also reflects the rapid evolution of the healthcare sector's capabilities and embodies the hospital's commitment to Dubai's vision of providing the highest standards of comprehensive healthcare for all members of the community, including children.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
a day ago
- Al Etihad
Cleveland Clinic Abu Dhabi marks another milestone with life-saving double lung transplant of Guatemalan patient
1 Aug 2025 00:37 ABU DHABI (ALETIHAD)Cleveland Clinic Abu Dhabi has cemented its position as a global leader in complex medical care with the successful double lung transplant of a 66-year-old patient from Guatemala. Performed by a multidisciplinary team from the hospital's Heart, Vascular & Thoracic Institute and Integrated Hospital Institute, the life-saving procedure is a powerful testament to the hospital's commitment and track record of delivering world-class care across borders. This milestone underlines Cleveland Clinic Abu Dhabi's dedication to expanding access to advanced, high-quality care accessible on a global scale. Oscar Romero López Guillén, who had been battling end-stage pulmonary fibrosis, arrived in Abu Dhabi after exhausting medical options in South Asia, Latin America, Europe, and the United States. Dependent on oxygen 24 hours a day and struggling with even the simplest physical tasks, Oscar faced an uncertain future until he discovered Cleveland Clinic Abu Dhabi's transplant with pulmonary fibrosis in 2016 in Guatemala after a prolonged cough, his condition progressively worsened over nearly a decade. Despite consultations in multiple countries and facing challenging issues like citizenship requirements and limited transplant capabilities and facilities, Oscar remained hopeful. Finally, in late 2024, the Cleveland Clinic global referral system connected him to Cleveland Clinic Abu Dhabi, offering him a new lease on life through the hospital's renowned Lung Transplant Georges-Pascal Haber, Chief Executive Officer at Cleveland Clinic Abu Dhabi, said, 'Oscar's journey is a powerful reminder of what Cleveland Clinic Abu Dhabi stands for, providing world-class care to patients across the globe. Our multi-organ transplant programme, one of the first in the region, is more than just advanced medical excellence; it's about expertise, compassionate care, and the extraordinary impact of the UAE's Hayat organ donation programme. We are honoured to be a place where both local and international patients can find hope and a second chance. At Cleveland Clinic Abu Dhabi, we are committed to ensuring that access to life-saving treatments knows no borders.'Dr. Usman Ahmad, Chair of Thoracic Surgery and Lung Transplantation, Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi, said, "Upon arrival at Cleveland Clinic Abu Dhabi, Oscar's lungs were barely functioning. Remarkably, he had endured such severe limitations for nearly a decade. After a thorough evaluation by our multidisciplinary lung transplant team, he was listed and underwent a double lung transplant a few weeks later. Today, just weeks after the surgery, Oscar has regained full function, with normal oxygen levels, excellent exercise capacity, and a normal quality of life. His recovery is a testament to the expertise of our team and our ability to provide life-changing care."Upon receiving Oscar's medical records, Cleveland Clinic Abu Dhabi's multidisciplinary team, comprising surgical lung transplant specialists and other critical care experts, immediately studied his case in detail. The family was swiftly enrolled in the lung transplant programme, and within weeks, they received the life-changing news that a matching donor organ had become available. Less than a week later, Oscar was admitted to the hospital and began preparations for his early 2025, after ensuring there were no complications, Oscar underwent a successful double lung transplant surgery. His recovery was swift and remarkable. Just 10 days after his admission, Oscar was discharged, breathing on his own, and ready to begin the next chapter of his life. Explaining his condition, Dr. Andres Obeso, Staff Physician, Thoracic Surgery at Cleveland Clinic Abu Dhabi, said: 'Oscar arrived at our doors speaking a different language, from a different continent, but the language of healing and helping is human and universal. When we reviewed his case, we found severely impaired lung function, yet no other major comorbidities. That combination, along with his resilience, made him a strong candidate for transplant. A successful lung transplant can add years to a patient's life. In Oscar's case, the surgery, intensive care, and post-transplant rehabilitation were all coordinated seamlessly by our multidisciplinary team. His journey is a testament to what's possible when world-class expertise meets an unshakable human spirit. These are the stories that inspire our mission to provide the best care, no matter where a patient comes from.'Cleveland Clinic Abu Dhabi is home to one of the region's first and most comprehensive lung transplant programmes, and one of the few worldwide that consistently welcomes international patients. Backed by an expert multidisciplinary team, the programme delivers end-to-end care, from in-depth pre-transplant evaluations to surgery and long-term recovery patients like Oscar, the hospital's dedicated International Patient Services team plays an essential role, seamlessly managing everything from travel and visa arrangements to accommodation and care coordination. This integrated approach ensures every patient's journey, from diagnosis to recovery, is as smooth and stress-free as hospital recently reported a 35% increase in international patient volume in 2024, with more than 10,000 international patient visits. Renowned for its excellence in complex care, Cleveland Clinic Abu Dhabi saw increased interest in its advanced services, mainly in the areas of cardiology, ophthalmology, neurology, and urology. Kuwait, Saudi Arabia, Pakistan, Bahrain, and the US are the top five countries from which international patients are travelling to Abu Dhabi in who now lives in the UAE for follow-up care, expressed his gratitude for the treatment that gave him a second chance, 'When I arrived at Cleveland Clinic Abu Dhabi, I felt like I had come to Heaven on Earth. The level of care, the kindness of the nurses, the professionalism, it was something I had never experienced before.''For years, I lived attached to an oxygen tank 24 hours a day. It wasn't just physically exhausting; it was a constant reminder that I could stop breathing at any moment. It was frightening, isolating, and incredibly expensive.'What amazed me most was how quickly everything happened. Throughout my long journey, no other hospital could provide an organ in time, but within weeks of arriving here, I was already preparing for surgery. Today, I can breathe, walk, and live again. I thank God, and I thank the incredible team at Cleveland Clinic Abu Dhabi who made this miracle possible,' Oscar added. Oscar's story is a reflection of Cleveland Clinic Abu Dhabi's expanding role in shaping the UAE's future as a global hub for complex care. As a centre of excellence in specialities such as adult cardiac surgery and stroke, the hospital continues to push the boundaries of what's possible in medicine. Powered by its collaboration with the Department of Health – Abu Dhabi (DoH), M42, the broader Cleveland Clinic network, and international partners, Cleveland Clinic Abu Dhabi is delivering world-class outcomes and advancing the nation's vision of becoming a destination for medical innovation, excellence, and deeply human-centred care.
Al Etihad
3 days ago
- Al Etihad
Department of Health – Abu Dhabi launches Rewarding Exceptional Quality programme, recognising excellence by healthcare providers
30 July 2025 16:39 ABU DHABI (ALETIHAD)The Department of Health – Abu Dhabi (DoH) has launched a new value-based healthcare initiative under its Rewarding Exceptional Quality programme, aimed at incentivising healthcare providers based on the quality of care they programme will initially focus on fertility services and is set to expand to other clinical areas in subsequent phases, further reinforcing Abu Dhabi's position as a world-class healthcare initiative is part of Abu Dhabi's continued commitment to elevating the standard of care across the emirate, where the department will monitor the performance of healthcare facilities based on specific models and facilities will be rewarded with additional incentives for achieving set performance goals within a specified timeframe, such as improving patient outcomes, utilising best medical practices, boosting patient safety, and enhancing the patient Excellency Dr Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi – Abu Dhabi, said, 'At the Department of Health – Abu Dhabi, we are committed to raising the bar for healthcare quality in Abu Dhabi. The launch of the Rewarding Exceptional Quality programme reflects our ambition to drive meaningful improvements in clinical performance while rewarding providers that go above and beyond in delivering safe, effective, and patient-centred care.''Fertility services were chosen as the starting point given their strategic importance to public health and the profound impact they have on families. Abu Dhabi has already made tremendous strides in advancing reproductive medicine, and this programme will help accelerate progress even further.'Abu Dhabi has become a leading destination for fertility care, driven by innovation in treatments such as egg freezing, in vitro fertilisation (IVF), and embryo 2025, the Department of Health – Abu Dhabi reported that IVF success rates in the emirate exceeded 51 percent, among the highest globally, with more than 6,180 IVF cycles performed in 2024 emirate is home to 14 advanced fertility centres and more than 2,800 healthcare professionals in obstetrics and gynaecology. This includes 700 specialists and consultants, 375 midwives, and 45 facilities dedicated to women's health.
Al Etihad
3 days ago
- Al Etihad
FDA recommends restricting 7-OH opioid products found in some vapes
29 July 2025 19:44 ABU DHABI (ALETIHAD)The US Food and Drug Administration has recommended a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH1) products that are commonly found in vapes. The FDA is specifically targeting 7-OH, a concentrated byproduct of the kratom plant that is increasingly recognised as having potential for abuse because of its ability to bind to opioid receptors. 'Today, we're taking action on 7-OH as a critical step in the fight against opioid addiction,' said HHS Secretary Robert F. Kennedy, Jr.'We will protect the health of our nation's youth as we advance our mission to Make America Healthy Again.'This recommendation follows a thorough medical and scientific analysis by the FDA, and is one of several efforts to address the agency's concerns around the growing availability and use of 7-OH opioid products. There are no FDA-approved 7-OH drugs, 7-OH is not lawful in dietary supplements and 7-OH cannot be lawfully added to conventional foods. 'Vape stores are popping up in every neighborhood in America, and many are selling addictive products like concentrated 7-OH. After the last wave of the opioid epidemic, we cannot get caught flat-footed again,' said FDA Commissioner Marty Makary, M.D., M.P.H.'7-OH is an opioid that can be more potent than morphine. We need regulation and public education to prevent another wave of the opioid epidemic.'The FDA is particularly concerned with the growing market of 7-OH products that may be especially appealing to children and teenagers, such as fruit-flavored gummies and ice cream cones. These products may not be clearly or accurately labeled as to their 7-OH content and are sometimes disguised or marketed as kratom. The FDA has issued a letter to health care professionals, and has warned consumers about the risks associated with 7-OH products. Source: Aletihad - Abu Dhabi
